Optical coherence tomography-based decision making in exudative age-related macular degeneration: comparison of time- vs spectral-domain devices

被引:37
作者
Cukras, C. [2 ]
Wang, Y. D. [1 ]
Meyerle, C. B. [2 ]
Forooghian, F. [2 ]
Chew, E. Y. [2 ]
Wong, W. T. [1 ]
机构
[1] NEI, Unit Neuron Glia Interact, NIH, Bethesda, MD 20892 USA
[2] NEI, Div Epidemiol & Clin Res, NIH, Bethesda, MD 20892 USA
关键词
age-related macular degeneration; optical coherence tomography; clinical trials; neovascularization; anti-angiogenic treatment; RETINAL THICKNESS MEASUREMENTS; BEVACIZUMAB AVASTIN THERAPY; REPRODUCIBILITY; REPEATABILITY; RANIBIZUMAB; AGREEMENT;
D O I
10.1038/eye.2009.211
中图分类号
R77 [眼科学];
学科分类号
100212 [眼科学];
摘要
Purpose To determine whether optical coherence tomography (OCT) device-type influences clinical grading of OCT imaging in the context of exudative age-related macular degeneration (AMD). Methods Ninety-six paired OCT scans from 49 patients with active exudative AMD were obtained on both the time-domain Stratus OCT system and the spectral-domain Cirrus OCT system at the same visit. Three independent graders judged each scan for the presence of intraretinal fluid (IRF) or subretinal fluid (SRF). The degree of grader consensus was evaluated and the ability of the systems to detect the presence of disease activity was analysed. Results Cirrus OCT generated a higher degree of inter-grader consensus than Stratus OCT with higher intraclass correlation coefficients for all parameters analysed. A pair-wise comparison of Cirrus OCT with Stratus OCT systems revealed that Cirrus-based gradings more frequently reported the presence of SRF and IRF and detected overall neovascular activity at a higher rate (P<0.05) compared with Stratus-based gradings. Conclusions The choice of time-domain (Stratus) vs spectra-domain (Cirrus) OCT systems has a measurable impact on clinical decision making in exudative AMD. Spectral-domain OCT systems may be able to generate more consensus in clinical interpretation and, in particular cases, detect disease activity not detected by time-domain systems. Clinical trials using OCT-based clinical evaluations of exudative AMD may need to account for these inter-system differences in planning and analysis. Eye (2010) 24, 775-783; doi:10.1038/eye.2009.211; published online 21 August 2009
引用
收藏
页码:775 / 783
页数:9
相关论文
共 16 条
[1]
Increased-resolution OCT thickness mapping of the human macula: A statistically based registration [J].
Bernardes, Rui ;
Santos, Torcato ;
Cunha-Vaz, Jose .
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2008, 49 (05) :2046-2052
[2]
Anti-VEGF agents in the treatment of neovascular age-related macular degeneration: Applying clinical trial results to the treatment of everyday patients [J].
Brown, David M. ;
Regillo, Carl D. .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 2007, 144 (04) :627-637
[3]
Results and repeatability of retinal thickness measurements from certification submissions [J].
Danis, Ronald P. ;
Fisher, Marian R. ;
Lambert, Ericka ;
Goulding, Anne ;
Wu, Deborah ;
Lee, Li-Yin .
ARCHIVES OF OPHTHALMOLOGY, 2008, 126 (01) :45-50
[4]
An optical coherence tomography-guided, variable dosing regimen with intravitreal ranibizumab (lucentis) for neovascular age-related macular degeneration [J].
Fung, Anne E. ;
Lalwani, Geeta A. ;
Rosenfeld, Philip J. ;
Dubovy, Sander R. ;
Michels, Stephan ;
Feuer, William J. ;
Puliafito, Carmen A. ;
Davis, Janet L. ;
Flynn, Harry W., Jr. ;
Esquiabro, Maria .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 2007, 143 (04) :566-583
[5]
Optical coherence tomography of age-related macular degeneration and choroidal neovascularization [J].
Hee, MR ;
Baumal, CR ;
Puliafito, CA ;
Duker, JS ;
Reichel, E ;
Wilkins, JR ;
Coker, JG ;
Schuman, JS ;
Swanson, EA ;
Fujimoto, JG .
OPHTHALMOLOGY, 1996, 103 (08) :1260-1270
[6]
Agreement among ophthalmologists in evaluating fluorescein angiograms in patients with neovascular age-related macular degeneration for photodynamic therapy eligibility (FLAP-Study) [J].
Holz, FG ;
Jorzik, J ;
Schutt, F ;
Flach, U ;
Unnebrink, K .
OPHTHALMOLOGY, 2003, 110 (02) :400-405
[7]
Optical coherence tomography to detect and manage retinal disease and glaucoma [J].
Jaffe, GJ ;
Caprioli, J .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 2004, 137 (01) :156-169
[8]
Angiographic and optical coherence tomographic results of the MARINA study of ranibizumab in neovascular age-related macular degeneration [J].
Kaiser, Peter K. ;
Blodi, Barbara A. ;
Shapiro, Howard ;
Acharya, Nisha R. .
OPHTHALMOLOGY, 2007, 114 (10) :1868-1875
[9]
Evaluation of Optical Coherence Tomography Retinal Thickness Parameters for Use in Clinical Trials for Neovascular Age-Related Macular Degeneration [J].
Keane, Pearse A. ;
Liakopoulos, Sandra ;
Jivrajka, Renu V. ;
Chang, Karen T. ;
Alasil, Tarek ;
Walsh, Alexander C. ;
Sadda, Srinivas R. .
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2009, 50 (07) :3378-3385
[10]
Reproducibility of retinal mapping using optical coherence tomography [J].
Massin, P ;
Vicaut, E ;
Haouchine, B ;
Erginay, A ;
Paques, M ;
Gaudric, A .
ARCHIVES OF OPHTHALMOLOGY, 2001, 119 (08) :1135-1142